Omalizumab in Food Allergy in Children: Current Evidence and Future Perspectives

Omalizumab in Food Allergy in Children: Current Evidence and Future Perspectives

Omalizumab (OMA) is gaining recognition as a promising therapeutic approach for IgE-mediated food allergies in pediatric patients. We conducted a review analyzing 22 studies, including randomized controlled trials, observational studies, and case reports, to evaluate the efficacy and safety of OMA i...

Full description

Saved in:
Bibliographic Details
Main Authors: Cristiana Indolfi, Alessandra Perrotta, Giulio Dinardo, Angela Klain, Carolina Grella, Paola Palumbo, Michele Miraglia del Giudice
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Life
Subjects:
omalizumab
food allergy
food allergies
food hypersensitivity
immunotherapy
immunoglobulin E
Online Access:https://www.mdpi.com/2075-1729/15/5/681
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2075-1729/15/5/681

Similar Items